Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
出版年份 2011 全文链接
标题
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
作者
关键词
-
出版物
NATURE GENETICS
Volume 44, Issue 2, Pages 165-169
出版商
Springer Nature
发表日期
2011-12-26
DOI
10.1038/ng.1041
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma
- (2011) Xiaomu Wei et al. HUMAN MUTATION
- dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions
- (2011) Xiaoming Liu et al. HUMAN MUTATION
- Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma
- (2011) Todd D Prickett et al. NATURE GENETICS
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- (2011) Xiaomu Wei et al. NATURE GENETICS
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype
- (2010) Nicolas Bisson et al. CELL CYCLE
- Haplo-insufficiency: a driving force in cancer
- (2010) Alice H Berger et al. JOURNAL OF PATHOLOGY
- Mutational and Functional Analysis Reveals ADAMTS18 Metalloproteinase as a Novel Driver in Melanoma
- (2010) X. Wei et al. MOLECULAR CANCER RESEARCH
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- MutationTaster evaluates disease-causing potential of sequence alterations
- (2010) Jana Marie Schwarz et al. NATURE METHODS
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- The UCSC Genome Browser database: update 2011
- (2010) P. A. Fujita et al. NUCLEIC ACIDS RESEARCH
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs and p53
- (2009) S C Naumann et al. BRITISH JOURNAL OF CANCER
- ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis
- (2009) Takayuki Iriyama et al. EMBO JOURNAL
- Identification of deleterious mutations within three human genomes
- (2009) S. Chun et al. GENOME RESEARCH
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
- (2009) Todd D Prickett et al. NATURE GENETICS
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
- (2009) Prateek Kumar et al. Nature Protocols
- BFAST: An Alignment Tool for Large Scale Genome Resequencing
- (2009) Nils Homer et al. PLoS One
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
- (2008) D. A. Solomon et al. CANCER RESEARCH
- Mixed-Lineage Kinase 1 and Mixed-Lineage Kinase 3 Subtype-Selective Dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: Optimization, Mixed-Lineage Kinase 1 Crystallography, and Oral in Vivo Activity in 1-Methyl-4-phenyltetrahydropyridine Models
- (2008) Robert L. Hudkins et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
- (2007) Kohsuke Takeda et al. Annual Review of Pharmacology and Toxicology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started